Blog Posts by Tag: Laboratory
Transforming Diagnostic Service Delivery: One Lab’s Experience Integrating a Digital Pathology Platform and an LIS
Medicine has gone digital. This digital transformation can be seen in the rapid adoption of telemedicine, the use of digital radiology and medical imaging, and in precision medicine molecular and genomic testing. This post looks at how one laboratory, Cernostics, went digital through the implementation of a whole slide imaging and digital pathology platform integrated with an LIS. This integrated...
Addressing EKRA Sales Force Compensation Mandates to Improve Both Compliance and Profitability
EKRA - Eliminating Kickbacks in Recovery Act - is a relatively new law that has some important implications for all diagnostic laboratories, and not just toxicology labs, which precipitated the legislation. Passed in October 2018, it was widely understood the law was intended to combat the opioid crisis. Recently, due in part to COVID-19 and government concerns over fraud and abuse, there has...
Delta Variant Impact on Lab Testing Volumes
The impact of the SARS-CoV-2 Delta variant is increasingly severe. The CDC has determined this strain is nearly twice as contagious as previous variants and two studies indicate Delta patients are more likely to be hospitalized than those infected with Alpha or the original virus strains.1 97.4% of all U.S. COVID-19 cases stem from this variant.2Infection numbers are rising rapidly. On August 11...
How to Reduce Retro Authorizations to Improve Reimbursement
Enjoy the following content from our partner, Infinx. The reimbursement landscape for clinical labs and remote patient monitoring has never been so challenging or so precarious. Patient and third-party payor responsibility continues to shift, and there is no end in sight for ongoing changes and increases in government regulations and insurance requirements.In a rapidly changing and consumer-...
Top 3 Challenges in Community Oncology Revenue Cycle Management
Community oncology continues to experience a dramatic shift in market dynamics. Substantive developments include a proliferation of acquisitions, the CMS Merit-Based Incentive Payment System (MIPS) and larger shift to value-based reimbursement models, as well as exploration of precision medicine as the standard of care.Notable changes that directly constrain practice financial health include fee...
You Invested to Meet the Demand for COVID-19 Testing: How Do You Optimize that Investment Post-Pandemic?
At the beginning of the COVID-19 pandemic in the U.S., many laboratories invested in equipment, supplies, and personnel to manage the surge of COVID-19 test demand. For the laboratory information system (LIS), the backbone of the laboratory IT infrastructure, this meant new workflows, report templates, and instrument interfaces to handle the new COVID-19 Polymerase Chain Reaction (PCR) tests.Once...
University of Southern California (USC) Department of Pathology and Laboratory Medicine — An Outreach Success Story
The University of Southern California (USC) Department of Pathology and Laboratory Medicine is one of the largest and most acclaimed in the country, with nationally and internationally renowned physicians on its staff. When the team at USC decided to open an outreach laboratory to expand their lab services to the community, the department chose XIFIN, Inc. as its pathology laboratory information...
4 Ways to Maximize Revenue Regarding Genetic Testing
As genetic testing has continued to increase, reimbursements on genetic test claims remain a significant challenge for clinical laboratories and anatomic pathology groups.According to Concert Genetics, the number of total genetic tests in 2012 was 10,000. By year-end 2020, that number had grown to 166,450 tests. Not only is the number of tests increasing, but the testing is becoming more...
- 1 of 18
- next ›